ecNumber*3.4.24.82#turnoverNumber*1.16#turnoverNumberMaximum*#substrate*chondroitin 4-sulfate#commentary*in 100 mM NaCl#organism*Homo sapiens#ligandStructureId*2137#literature*680792#!ecNumber*3.4.24.82#turnoverNumber*0.072#turnoverNumberMaximum*#substrate*C6-(Gly-Pro-Hyp-Pro-Hyp-Gly)2-Gly-Pro-Hyp-Gly-Thr-Lys(Mca)-Gly-Glu-Leu-Glu-Gly-Arg-Gly-Thr-Lys(Dnp)-Gly-Ile-Ser-(Gly-Pro-Hyp-Pro-Hyp-Gly)2-Gly-Pro-Hyp-NH2#commentary*ADAMTS-4-2, at 25&Acirc;&deg;C#organism*Homo sapiens#ligandStructureId*18520#literature*680769#!ecNumber*3.4.24.82#turnoverNumber*0.433#turnoverNumberMaximum*#substrate*C6-(Gly-Pro-Hyp-Pro-Hyp-Gly)2-Gly-Pro-Hyp-Gly-Thr-Lys(Mca)-Gly-Glu-Leu-Glu-Gly-Arg-Gly-Thr-Lys(Dnp)-Gly-Ile-Ser-(Gly-Pro-Hyp-Pro-Hyp-Gly)2-Gly-Pro-Hyp-NH2#commentary*ADAMTS-4-2, at 25&Acirc;&deg;C#organism*Homo sapiens#ligandStructureId*18520#literature*680769#!ecNumber*3.4.24.82#turnoverNumber*0.012#turnoverNumberMaximum*#substrate*[C6-(Gly-Pro-Hyp)5-Gly-Thr-Lys(7-amido-4-methylcoumarin)-Gly-Glu-Leu-Glu-Gly-Arg-Gly-Thr-Lys(2,4-dinitrophenyl)-Gly-Ile-Ser-(Gly-Pro-Hyp)5-NH2]3#commentary*ADAMTS-4-2, at 25&Acirc;&deg;C#organism*Homo sapiens#ligandStructureId*#literature*680769#!ecNumber*3.4.24.82#turnoverNumber*0.181#turnoverNumberMaximum*#substrate*[C6-(Gly-Pro-Hyp)5-Gly-Thr-Lys(7-amido-4-methylcoumarin)-Gly-Glu-Leu-Glu-Gly-Arg-Gly-Thr-Lys(2,4-dinitrophenyl)-Gly-Ile-Ser-(Gly-Pro-Hyp)5-NH2]3#commentary*ADAMTS-4-2, at 25&Acirc;&deg;C#organism*Homo sapiens#ligandStructureId*#literature*680769#!ecNumber*3.4.24.82#turnoverNumber*1.49#turnoverNumberMaximum*#substrate*Aggrecan#commentary*in 100 mM NaCl#organism*Homo sapiens#ligandStructureId*#literature*680792#